URO-1, Inc. is a life sciences company dedicated to advancing the tools and workflows used in soft tissue biopsy diagnostics.
Vanquish uses ultrasound, transurethral and electromagnetically guided thermotherapy to ablate prostate tissue.
Miniaturized percutaneous techniques, flexible ureteroscopy, and outpatient protocols have shortened hospital stays and improved recovery, reshaping quality-of-life outcomes for patients.
Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26), taking place in London from 13–16 March 2026.
Copyright: © 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Congenital lower urinary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results